MFDS — authorised 30 May 2007
- Marketing authorisation holder: PF PRISM CV
- Status: likely_approved
🇰🇷 Torisel in South Korea
MFDS authorised Torisel on 30 May 2007
Marketing authorisation
Torisel in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Torisel approved in South Korea?
Yes. MFDS authorised it on 30 May 2007.
Who is the marketing authorisation holder for Torisel in South Korea?
PF PRISM CV holds the South Korean marketing authorisation.